The Epstein-Barr virus (EBV) is the most common human virus, implicated in the pathogenesis of several human tumors, particularly B-cells lymphoma 1 . EBV-induced lymphoproliferative disorders (EBV-LPDs) are the result of the outgrowth of EBV-infected B-cells, that would normally controlled by an effective EBV-specific cytotoxic T-cell response 2, 3 . The association between EBV and follicular lymphoma (FL) is not well recognized and only 10 cases have been previously described 4, 5, 6, 7 . Nine of them showed EBER-positivity in >75% of tumour cells and one case in ~5-10%. EBV-positivity was associated with grade 3 FL (9/10), CD30 expression and rapid progression of disease 6 . However, it is still unclear whether EBV infection is an early event in the development of FL or a late event that may contribute to the progression of a pre-existing lymphoma. We describe a case of EBV-positive diffuse large B-cell lymphoma (DLBCL) evolved from a previous FL.
In Notwithstanding these evidences, the precise role of EBV lytic activity and its ability to reshape the TME remains elusive and further investigation is warranted.
However, our findings expand the spectrum of recognized EBV-associated B-cell lymphomas and raise the question as to whether EBV association should be investigated in cases of FL to establish its relationship to lymphomagenesis or transformation. 
